Patients Are Flocking to Compounded Weight-Loss Drugs, but Are They Safe?

JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.27251. Online ahead of print.
No abstract available

Plain language summary

This Medical News article discusses safety concerns around compounded semaglutide and tirzepatide, including how clinicians can help prevent dosing errors.